New Study Links High Systemic Immune-Inflammation Index to Atopic Dermatitis Risk in Adults with BMI Less Than 30 Medha Baranwal12 Sept 2024 10:00 PM ISTUSA: A recent cross-sectional study using data from the National Health and Nutrition Examination Survey (NHANES) from 2001 to 2006 reveals a...
Eli Lilly, EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries Ruchika Sharma8 Sept 2024 10:00 AM ISTIndianapolis: Eli Lilly and Company and EVA Pharma have announced that the companies have entered into an agreement to expand access to...
Obese children more likely to develop skin conditions related to the immune system, suggests study Dr. Kamal Kant Kohli23 Aug 2024 9:15 AM ISTChildhood obesity can contribute to the development of common immune-mediated skin diseases (IMSDs), such as alopecia areata, atopic dermatitis, and...
Dupilumab Shows Promising Results for Hair Regrowth in Pediatric Alopecia Areata, with No New Safety Concerns: Study Medha Baranwal17 Aug 2024 9:30 AM ISTUSA: A real-world, single-center observational study revealed that dupilumab significantly enhanced hair regrowth in pediatric patients with alopecia...
Dupilumab use among pediatric atopic dermatitis patients may improve comorbid asthma, finds study Dr. Shravani Dali16 Aug 2024 8:00 AM ISTDupilumab use among pediatric atopic dermatitis patients may improve comorbid asthma, finds a study published in the Pediatric Allergy and...
Cendakimab effective, safe, and well-tolerated in patients with moderate to severe atopic dermatitis: JAMA Dr Riya Dave13 Aug 2024 8:30 AM ISTResearchers have found that cendakimab, an interleukin-13 (IL-13) targeting monoclonal antibody, significantly reduces the severity of atopic...
Submit clinical study data conducted in adults: CDSCO Panel Tells Sanofi on atopic dermatitis drug Dr. Divya Colin4 Aug 2024 6:00 PM ISTNew Delhi: Responding to the protocol amendment proposal for Amlitelimab study, the Subject Expert Committee (SEC) functional under the Central Drug...
Cendakimab Shows Efficacy and Safety in Treating Moderate to Severe Atopic Dermatitis: Results from Clinical Trial Medha Baranwal2 Aug 2024 8:30 PM ISTUSA: In a phase 2 randomized clinical trial of 221 patients with moderate to severe atopic dermatitis (AD), treatment with cendakimab, an...
Prolonged Oral Corticosteroid Use Slightly Increases Adverse Event Risk in Atopic Dermatitis Patients: JAMA Dr Riya Dave24 July 2024 8:00 PM ISTResearchers discovered that, in patients with atopic dermatitis, long-term use of oral corticosteroids was slightly associated with an increased risk...
JnJ strengthens atopic dermatitis pipeline with acquisition of Yellow Jersey Therapeutics Ruchika Sharma14 July 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of Yellow Jersey, a demerged...
Phototherapy Proven Effective for Asian Pediatric Atopic Dermatitis, Study Shows Dr Riya Dave10 July 2024 3:30 AM ISTResearchers have found in a recent study that phototherapy is an effective second-line treatment for moderate-to-severe atopic dermatitis in the Asian...
Abrocitinib therapy effective in patients with Atopic dermatitis: Study Jacinthlyn Sylvia8 July 2024 5:15 AM ISTA new study published in the International Journal of Dermatology suggests that abrocitinib is an effective therapy for atopic dermatitis (AD) since...
